Publications by authors named "Helene Poirel"

Claim this Profile
L
Long-term survival for myeloid neoplasms and national health expenditure: A EUROCARE-6 retrospective, population-based study.
Claudia Vener, Roberto Lillini, Roberta De Angelis, Simone Bonfarnuzzo, Hélène A Poirel

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Burden in Adolescents and Young Adults in Belgium: Trends to Incidence Stabilisation in Recent Years with Improved Survival.
Fabienne Van Aelst, Bart Van Gool, Nancy Van Damme, Hélène A Poirel

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib Adherence and Persistence in Patients with Chronic Myeloid Leukemia in Belgium: Evidence from Real-World Data.
Sandra Michiels, Sandra Tricas-Sauras, Adriano Salaroli, Dominique Bron, Philippe Lewalle, Hélène A Poirel

Patient Prefer Adherence· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic counselling legislation and practice in cancer in EU Member States.
J Matt McCrary, Els Van Valckenborgh, Hélène A Poirel, Robin de Putter, Jeroen van Rooij

Eur J Public Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policy brief - cancer research in Belgium.
Gordana Raicevic Toungouz, Hélène A Poirel, Gabrielle Schittecatte, Marc Van Den Bulcke,

Arch Public Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Policy brief of the Belgian Europe's Beating Cancer Plan mirror group: children, adolescents and young adults with cancer.
Hélène A Poirel, Gabrielle Schittecatte, Fabienne Van Aelst,

Arch Public Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the genomic landscape: Results of the Beyond 1 Million Genomes (B1MG) pilot in Belgium towards Genomic Data Infrastructure (GDI).
Tugce Schmitt, Hélène A Poirel, Emilie Cauët, Marie Delnord, Marc Van den Bulcke

Health Policy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 1+Million Genomes Minimal Dataset for Cancer.
Michela Riba, Cinzia Sala, Aedin C Culhane, Åsmund Flobak, Attila Patocs, Helene A Poirel

Nat Genet· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(Cyclin F) as a Candidate Gene for Familial Hodgkin Lymphoma: Additional Evidence for the Importance of Mitotic Checkpoint Defects in Tumorigenesis.
Elsa Khoury, Hiba Maalouf, Antonella Mendola, Simon Boutry, Alessandra Camboni, Hélène A Poirel

Hemasphere· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological Trends of Haematological Malignancies in Belgium 2004-2018: Older Patients Show the Greatest Improvement in Survival.
Kris Henau, Tim Tambuyzer, Bart Van Gool, Liesbet Van Eycken, Hélène A Poirel

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE).
Riccardo Saccardi, Hein Putter, Dirk-Jan Eikema, María Paula Busto, Eoin McGrath, Hélène A Poirel

Bone Marrow Transplant· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials.
Claudia Vener, Silvia Rossi, Pamela Minicozzi, Rafael Marcos-Gragera, Hélène A Poirel

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study.
Willem Daneels, Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Hélène A Poirel

Front Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, Laetitia Largeaud, Vincent Fregona, Hélène A Poirel

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning-Based Extraction of Breast Cancer Receptor Status From Bilingual Free-Text Pathology Reports.
Antoine Pironet, Hélène A Poirel, Tim Tambuyzer, Harlinde De Schutter, Lien van Walle

Front Digit Health· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
John A Snowden, Riccardo Saccardi, Kim Orchard, Per Ljungman, Rafael F Duarte, Hélène A Poirel

Bone Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
John A Snowden, Riccardo Saccardi, Kim Orchard, Per Ljungman, Rafael F Duarte, Hélène A Poirel

Bone Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.
Hélène A Poirel, Marijke Vanspauwen, Gilles Macq, Anke De Geyndt, Johan Maertens

Bone Marrow Transplant· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of two new high-grade B-cell lymphoma cell lines with MYC and BCL2 rearrangements that are suitable for in vitro drug sensitivity studies.
Marie-Sophie Dheur, Hélène A Poirel, Geneviève Ameye, Gaëlle Tilman, Pascale Saussoy

Leuk Lymphoma· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of hereditary angioedema type 1 with developmental anomalies due to a large and unusual de novo pericentromeric rearrangement of chromosome 11 spanning the entire C1 inhibitor gene (SERPING1).
Didier G Ebo, Bettina Blaumeiser, Frank R Kooy, Sigri Beckers, Athina L Van Gasse, Hélène A Poirel

J Allergy Clin Immunol Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Potential Mechanisms Controlling the Catalase Expression in Breast Cancer Cells.
Christophe Glorieux, Juan Marcelo Sandoval, Nicolas Dejeans, Sandrine Nonckreman, Khadija Bahloula, Hélène A Poirel

Oxid Med Cell Longev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients.
Jean Donadieu, Marie Lamant, Claire Fieschi, Flore Sicre de Fontbrune, Aurélie Caye, Hélène A Poirel

Haematologica· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma.
Eric Van Den Neste, Marc André, Thomas Gastinne, Aspasia Stamatoullas, Corinne Haioun, Hélène A Poirel

Haematologica· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Reports in Oncological Medicine Myoepithelioma: A New Rearrangement Involving the Locus in a Case of Multiple Bone and Soft Tissue Lesions.
Géraldine Pairet, Gaëlle Tilman, Rafaël Sciot, Thomas Schubert, Vasiliki Perlepe, Hélène A Poirel

Case Rep Oncol Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Flavia Zita Francies, Rosalind Wainwright, Janet Poole, Kim De Leeneer, Ilse Coene, Hélène A Poirel

DNA Repair (Amst)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis